Utah Medical Products Inc (UTMD) shareholders
Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Brandes Investment Partners, LP Joint filing with Datum One Series Trust (6.90%) | 475,158 | 14.90% | 13G (passive) amendment | Jun 30, 2026 |
| T. Rowe Price Investment Management, Inc. | 269,166 | 7.40% | 13G (passive) amendment | Feb 14, 2024 |
| Renaissance Technologies Holdings Corporation Joint filing with Renaissance Technologies LLC (6.70%) | 230,614 | 6.70% | 13G (passive) amendment | Sep 30, 2024 |
| Dimensional Fund Advisors LP | 197,466 | 6.10% | 13G (passive) amendment | Jun 30, 2025 |
| Renaissance Technologies LLC Joint filing with Renaissance Technologies Holdings Corporation (5.52%) | 175,814 | 5.52% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock, Inc. | 172,684 | 5.30% | 13G (passive) | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of UTMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Brandes Investment Partners, LP | 475,158 | 14.92% | $32.78M | +25,879 | 0.23% |
| BlackRock, Inc. | 203,690 | 6.40% | $14.05M | +16,041 | 0.00% |
| Dimensional Fund Advisors LP | 198,817 | 6.24% | $13.72M | +909 | 0.00% |
| Renaissance Technologies LLC | 175,814 | 5.52% | $12.13M | −8,300 | 0.02% |
| Vanguard Capital Management LLC | 134,535 | 4.23% | $9.28M | −4,025 | 0.00% |
| Geode Capital Management, LLC | 108,048 | 3.39% | $7.45M | −12,049 | 0.00% |
| Minerva Advisors LLC | 93,615 | 2.94% | $6.46M | – | 4.08% |
| Hotchkis & Wiley Capital Management LLC | 85,231 | 2.68% | $5.88M | −3,900 | 0.02% |
| Rice Hall James & Associates, LLC | 71,363 | 2.24% | $4.92M | +3,481 | 0.24% |
| Morgan Stanley | 69,671 | 2.19% | $4.81M | +20,870 | 0.00% |
| State Street Corp | 63,937 | 2.01% | $4.43M | −465 | 0.00% |
| Quantinno Capital Management LP | 43,074 | 1.35% | $2.97M | +13,233 | 0.00% |
| UBS Group AG | 34,369 | 1.08% | $2.37M | −2,547 | 0.00% |
| Bank of New York Mellon Corp | 34,263 | 1.08% | $2.36M | +2,181 | 0.00% |
| Northern Trust Corp | 30,104 | 0.95% | $2.08M | −188 | 0.00% |
| Huber Capital Management LLC | 29,009 | 0.91% | $2.00M | −6,906 | 0.29% |
| Cardinal Capital Management | 27,094 | 0.85% | $1.88M | +551 | 0.23% |
| Everett Harris & Co /Ca/ | 23,933 | 0.75% | $1.65M | −1,631 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 21,938 | 0.69% | $1.52M | +3,638 | 0.00% |
| O'Shaughnessy Asset Management, LLC | 21,683 | 0.68% | $1.50M | +396 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 114 | 2M | 72.8% | 7 / 48 | 34 / 10 | 0M | 0M |
| Q1 2026 | 119 | 2M | 71.2% | 13 / 48 | 29 / 9 | 0M | 0M |
| Q4 2025 | 117 | 2M | 65.9% | 10 / 33 | 50 / 9 | 0M | 0M |
| Q3 2025 | 117 | 2M | 68.4% | 14 / 39 | 34 / 8 | 0M | 0M |
| Q2 2025 | 112 | 2M | 68.0% | 17 / 38 | 39 / 14 | 0M | 0M |
| Q1 2025 | 109 | 2M | 70.4% | 15 / 35 | 36 / 17 | 0M | 0M |
| Q4 2024 | 112 | 2M | 72.4% | 19 / 40 | 36 / 17 | 0M | 0M |
| Q3 2024 | 110 | 2M | 77.8% | 19 / 43 | 26 / 9 | 0M | 0M |
| Q2 2024 | 101 | 2M | 78.0% | 20 / 40 | 31 / 19 | 0M | 0M |
| Q1 2024 | 100 | 3M | 83.6% | 21 / 36 | 31 / 10 | 1M | 0M |
| Q4 2023 | 89 | 3M | 81.4% | 7 / 34 | 30 / 9 | 0M | 0M |
| Q3 2023 | 91 | 3M | 80.7% | 10 / 41 | 24 / 9 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
137 funds held UTMD in Q2 2026, 38% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of UTMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Brandes Small Cap Value Fund | 218,681 | 6.87% | $15.08M | 2.37% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 97,788 | 3.07% | $6.75M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 67,441 | 2.12% | $4.65M | 0.01% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 36,560 | 1.15% | $2.58M | 0.01% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund | 33,689 | 1.06% | $2.38M | 0.01% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 33,310 | 1.05% | $2.30M | 0.00% | Jun 30, 2026 |
| Fidelity Small-Mid Multifactor ETF | 31,903 | 1.00% | $2.25M | 0.09% | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 30,301 | 0.95% | $2.14M | 0.03% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 28,429 | 0.89% | $1.96M | 0.01% | Jun 30, 2026 |
| U.S. Targeted Value Portfolio | 21,809 | 0.68% | $1.54M | 0.01% | Jul 31, 2026 |
| Hotchkis and Wiley Small Cap Diversified Value Fund | 21,800 | 0.68% | $1.50M | 0.16% | Jun 30, 2026 |
| U.S. Small Cap Portfolio | 21,622 | 0.68% | $1.52M | 0.01% | Jul 31, 2026 |
| Dimensional U.S. Targeted Value ETF | 19,149 | 0.60% | $1.35M | 0.01% | Jul 31, 2026 |
| SmallCap Value Fund II | 16,403 | 0.52% | $1.16M | 0.09% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 15,481 | 0.49% | $1.03M | 0.01% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kevin L. Cornwell | Chairman, CEO, Director | 189,472 | 5.95% | Oct 29, 2026 |
| Brian Koopman | Principal Financial Officer | 782 | 0.02% | May 29, 2026 |
| Paul O. Richins | Director | 43,144 | 1.36% | Jul 1, 2026 |
| Kevin Timken | Director | – | – | Dec 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kevin L. Cornwell Chairman, CEO, Director | Oct 29, 2026 | Buy | +1,000 | $66.75 | $66.75K | 189,472 |
| Paul O. Richins Director | Jun 29, 2026 | Gift | −150 | $73.07 | $10.96K | 20,765 |
| Brian Koopman Principal Financial Officer | May 28, 2026 | Gift | −50 | $66.27 | $3.31K | 782 |
| Brian Koopman Principal Financial Officer | Sep 4, 2025 | Gift | −50 | $62.75 | $3.14K | 832 |
| Paul O. Richins Director | Aug 25, 2025 | Gift | −100 | $60.34 | $6.03K | 21,136 |
| Brian Koopman Principal Financial Officer | Jul 18, 2024 | Gift | −50 | $71.61 | $3.58K | 882 |
| Paul O. Richins Director | May 17, 2024 | Gift | −225 | $69.72 | $15.69K | 21,236 |
| Brian Koopman Principal Financial Officer | Jun 15, 2023 | Gift | −60 | $94.31 | $5.66K | 932 |
| Paul O. Richins Director | May 18, 2023 | Sale | −700 | $93.47 | $65.43K | 21,461 |
| Paul O. Richins Director | Mar 17, 2023 | Gift | −150 | $92.50 | $13.88K | 22,161 |
| Barbara A. Payne Director | Feb 8, 2023 | Gift | −500 | $90.00 | $45.00K | 4,838 |
| Brian Koopman Principal Financial Officer | Dec 6, 2022 | Option exercise | +500 | $74.64 | $37.32K | 992 |
| Brian Koopman Principal Financial Officer | Dec 6, 2022 | Tax withholding | −366 | $101.88 | $37.29K | 492 |
| Paul O. Richins Director | Nov 18, 2022 | Sale | −449 | $90.81 | $40.77K | 22,311 |
| Paul O. Richins Director | Nov 17, 2022 | Sale | −161 | $90.00 | $14.49K | 22,760 |
| Paul O. Richins Director | Nov 11, 2022 | Sale | −40 | $92.50 | $3.70K | 22,921 |
| Brian Koopman Principal Financial Officer | Oct 31, 2022 | Gift | −65 | $88.94 | $5.78K | 858 |
| Paul O. Richins Director | Jun 27, 2022 | Gift | −250 | $88.98 | $22.25K | 22,961 |
| Barbara A. Payne Director | May 11, 2022 | Sale | −2,000 | $85.20 | $170.40K | 5,338 |
| Barbara A. Payne Director | Feb 9, 2022 | Gift | −500 | $98.94 | $49.47K | 7,338 |
| Paul O. Richins Director | Dec 13, 2021 | Option exercise | +62 | $50.72 | $3.14K | 23,211 |
| Ernst G. Hoyer Director | Nov 24, 2021 | Sale | −4,900 | $126.41 | $619.41K | 5,000 |
| Ernst G. Hoyer Director | Nov 23, 2021 | Sale | −100 | $125.01 | $12.50K | 9,900 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Nov 22, 2021 | Gift | −2,000 | $124.75 | $249.50K | 188,472 |
| Barbara A. Payne Director | Nov 18, 2021 | Sale | −1,249 | $111.06 | $138.71K | 7,838 |
| Barbara A. Payne Director | Nov 17, 2021 | Sale | −751 | $111.06 | $83.41K | 9,087 |
| Brian Koopman Principal Financial Officer | Oct 27, 2021 | Tax withholding | −433 | $99.62 | $43.14K | 174 |
| Brian Koopman Principal Financial Officer | Oct 27, 2021 | Option exercise | +62 | $49.18 | $3.05K | 236 |
| Brian Koopman Principal Financial Officer | Oct 27, 2021 | Option exercise | +687 | $58.50 | $40.19K | 923 |
| Barbara A. Payne Director | Aug 30, 2021 | Sale | −1,000 | $88.48 | $88.48K | 9,838 |
| Barbara A. Payne Director | Aug 27, 2021 | Sale | −999 | $88.00 | $87.91K | 10,838 |
| Barbara A. Payne Director | Aug 25, 2021 | Sale | −1 | $88.00 | $88 | 11,837 |
| Paul O. Richins Director | Mar 11, 2021 | Gift | −225 | $92.48 | $20.81K | 23,149 |
| Barbara A. Payne Director | Mar 10, 2021 | Sale | −1,000 | $90.00 | $90.00K | 11,838 |
| Barbara A. Payne Director | Feb 9, 2021 | Gift | −500 | $90.99 | $45.50K | 12,838 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Jun 5, 2020 | Sale | −1,000 | $107.56 | $107.56K | 190,472 |
| Barbara A. Payne Director | Jun 5, 2020 | Sale | −1,000 | $108.00 | $108.00K | 13,338 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Jun 4, 2020 | Sale | −1,385 | $106.10 | $146.95K | 191,472 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Jun 3, 2020 | Sale | −5,000 | $106.42 | $532.10K | 192,857 |
| Barbara A. Payne Director | Jun 2, 2020 | Sale | −1,000 | $102.04 | $102.04K | 14,338 |
| Paul O. Richins Director | May 27, 2020 | Sale | −650 | $95.71 | $62.21K | 23,374 |
| Barbara A. Payne Director | May 27, 2020 | Sale | −1,000 | $95.00 | $95.00K | 15,338 |
| Barbara A. Payne Director | May 26, 2020 | Sale | −770 | $92.00 | $70.84K | 16,338 |
| Barbara A. Payne Director | May 21, 2020 | Sale | −230 | $92.37 | $21.25K | 17,108 |
| Barbara A. Payne Director | May 18, 2020 | Sale | −1,000 | $87.00 | $87.00K | 17,338 |
| Paul O. Richins Director | May 12, 2020 | Gift | −30 | $82.36 | $2.47K | 24,024 |
| Paul O. Richins Director | May 7, 2020 | Gift | −200 | $80.26 | $16.05K | 24,054 |
| Barbara A. Payne Director | Feb 20, 2020 | Gift | −500 | $96.00 | $48.00K | 18,338 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Dec 13, 2019 | Sale | −2,084 | $107.00 | $222.99K | 197,857 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Dec 12, 2019 | Sale | −584 | $107.05 | $62.52K | 199,941 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Nov 26, 2019 | Sale | −800 | $107.67 | $86.14K | 200,525 |
| Barbara A. Payne Director | Nov 19, 2019 | Sale | −694 | $102.25 | $70.96K | 18,838 |
| Barbara A. Payne Director | Nov 11, 2019 | Sale | −6 | $104.00 | $624 | 19,532 |
| Barbara A. Payne Director | Nov 8, 2019 | Gift | −300 | $101.17 | $30.35K | 19,538 |
| Kevin L. Cornwell Chairman, CEO, Secretary, Director | Nov 5, 2019 | Sale | −1,667 | $107.10 | $178.54K | 201,325 |
| Brian Koopman Principal Financial Officer | Nov 5, 2019 | Sale | −300 | $107.00 | $32.10K | 607 |
| Barbara A. Payne Director | Feb 27, 2019 | Sale | −1,521 | $85.75 | $130.43K | 19,838 |
| Barbara A. Payne Director | Feb 26, 2019 | Sale | −4 | $89.00 | $356 | 21,359 |
| Barbara A. Payne Director | Feb 20, 2019 | Sale | −1 | $92.00 | $92 | 21,363 |
| Barbara A. Payne Director | Feb 15, 2019 | Sale | −1,872 | $92.29 | $172.77K | 21,364 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Utah Medical Products's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,849 shares on Sep 17, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kevin L. Cornwell Officer | Jun 14, 2023 | 10,000 | $997.60K | Jun 14, 2023 | STOCK OPTION EXERCISE |
| Paul O. Richins Director | May 18, 2023 | 700 | $64.40K | May 18, 2023 | STOCK OPTION EXERCISE |
See a number that looks wrong?